Solid Biosciences to participate in upcoming investor conferences
Solid Biosciences Inc. (SLDB) said it will participate in upcoming investor conferences, as announced in a company update.
CHARLESTOWN, Mass., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc.
NASDAQ:SLDB (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:Each fires…